reports
- GlobalData Healthcare Department
Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Rev...
Exact Sciences Corp (EXAS) - Financial and Strategic SWOT Analysis Review Summary Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of colorectal cancer. The company’s product portfolio includes screening tests such as Cologuard test, a non-invasive stool-based deoxyribonucleic acid (DNA) screening product. Cologuard is indicated to screen adults aged 50 years or older, who are at average risk for colorectal cancer. Exact Scienc...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.